Bilkent University, School of Law, 2023
Istanbul, 2024
Related contents
19 October 2026
Period to increase minimum share capital of joint-stock and limited liability companies extended
Pursuant to the Communiqué on the Extension of the Period for Increasing the Share Capital of Joint-Stock and Limited Liability Companies…
13 October 2026
Borderline products: distinguishing medicinal products, medical devices and cosmetics under Turkish law
A critical consideration before placing health and personal care products on the market is determining their correct regulatory…
25 September 2026
Recent developments in healthcare legislation – Issue 2026/2
On 21 April 2026, the Turkish Medicines and Medical Devices Agency published amendments to the guideline with a view to streamlining the…
31 August 2026
Paksoy advises Point72 on its investment in HubX
On 28 August 2026, Point72 Private Investments, one of the world’s leading alternative investment firms, completed an investment of up to…
10 August 2026
Paksoy closes Fysol’s acquisition of shares of Beşler Glass Fiber
Fysol, a France-headquartered player in the glass fiber industry backed by private equity firm Blantyre Capital, has completed the…
13 April 2026
Recent developments in healthcare legislation – Issue 2026/1
The Guideline on Trust Practices in Clinical Trial Applications published by the Turkish Medicines and Medical Devices Agency was updated…
2 March 2026
Use of Health Declarations in Cosmetic Products
A health declaration is any statement or implication that a product or ingredients within its composition confers a benefit on human health…
14 January 2026
Paksoy advised Stellantis Group on the sale of BPF Pazarlama to TOFAŞ
Paksoy advised Stellantis Group on the sale of BPF Pazarlama to TOFAŞ.
7 January 2026
Paksoy advises Sanofi on the sale of a majority stake in its Lüleburgaz manufacturing facility
Paksoy advises Sanofi on the sale of a majority stake in its Lüleburgaz manufacturing facility.